HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Miriam Rottmann Selected Research

Miriam Rottmann Research Topics

Disease

5Carcinoma (Carcinomatosis)
01/2022 - 01/2017
5Neoplasms (Cancer)
01/2022 - 01/2018
4Ovarian Neoplasms (Ovarian Cancer)
01/2022 - 03/2020
1Mucinous Adenocarcinoma (Mucinous Carcinoma)
01/2022
1Ovarian Epithelial Carcinoma
03/2020
1Carcinogenesis
03/2020
1Macular Edema
12/2018
1Macular Degeneration (Age-Related Maculopathy)
12/2018
1Endometrial Neoplasms (Endometrial Cancer)
01/2018
1Endometrioid Carcinoma
01/2018
1Stomach Neoplasms (Stomach Cancer)
07/2016

Drug/Important Bio-Agent (IBA)

3Proteins (Proteins, Gene)FDA Link
03/2020 - 01/2017
2Biomarkers (Surrogate Marker)IBA
01/2022 - 03/2020
2histone H3 trimethyl Lys4IBA
11/2021 - 03/2020
2Histones (Histone)IBA
11/2021 - 03/2020
2Lysine (L-Lysine)FDA Link
11/2021 - 03/2020
2CateninsIBA
01/2018 - 01/2017
1Estrogen ReceptorsIBA
11/2021
1GTP-Binding Proteins (G-Protein)IBA
11/2021
1Small Interfering RNA (siRNA)IBA
11/2021
1PlatinumIBA
01/2021
1Bromodeoxyuridine (BrdU)IBA
03/2020
1Calcitriol (Calcijex)FDA LinkGeneric
03/2020
1hydroxide ionIBA
03/2020
1B7-H1 AntigenIBA
03/2020
1Immune Checkpoint InhibitorsIBA
05/2019
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
12/2018

Therapy/Procedure

3Therapeutics
03/2020 - 12/2018
1Salpingo-oophorectomy
01/2017
1Drug Therapy (Chemotherapy)
07/2016